相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA Methyltransferase Biomarker Analyses
Timothy Cloughesy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A. Brandes et al.
NEURO-ONCOLOGY (2016)
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo
Emese Szabo et al.
NEURO-ONCOLOGY (2016)
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D. Prados et al.
NEURO-ONCOLOGY (2015)
Transforming growth factor-β pathway activity in glioblastoma
Karl Frei et al.
ONCOTARGET (2015)
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma
Katharina Seystahl et al.
NEURO-ONCOLOGY (2015)
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Dieter Lemke et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Using the molecular classification of glioblastoma to inform personalized treatment
Adriana Olar et al.
JOURNAL OF PATHOLOGY (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors
Friedhelm Bladt et al.
CLINICAL CANCER RESEARCH (2013)
HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion (vol 123, pg 1402, 2013)
Kristina E. Hoot et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
RT-qPCR work-flow for single-cell data analysis
Anders Stahlberg et al.
METHODS (2013)
Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells
Barbara H. Rath et al.
PLOS ONE (2013)
Studying a Complex Tumor Potential and Pitfalls
Siyuan Zheng et al.
CANCER JOURNAL (2012)
Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β
Matthew E. Hardee et al.
CANCER RESEARCH (2012)
MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks
Michaela Medova et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background
Barry R. Davies et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Heterogeneity Maintenance in Glioblastoma: A Social Network
Rudy Bonavia et al.
CANCER RESEARCH (2011)
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
Francesca De Bacco et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The neurobiology of gliomas: from cell biology to the development of therapeutic approaches
Manfred Westphal et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Targeted therapy for high-grade glioma with the TGF-beta 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
U. Bogdahn et al.
NEURO-ONCOLOGY (2011)
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2011)
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
Yunqing Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
Judit Anido et al.
CANCER CELL (2010)
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Jason T. Huse et al.
NATURE REVIEWS CANCER (2010)
Prognostic Significance of c-Met Expression in Glioblastomas
Doo-Sik Kong et al.
CANCER (2009)
TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
Silvia Penuelas et al.
CANCER CELL (2009)
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
Hiroaki Ikushima et al.
CELL STEM CELL (2009)
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
James W. Welsh et al.
RADIATION ONCOLOGY (2009)
EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells
Barbara S. Paugh et al.
FASEB JOURNAL (2008)
Transforming Growth Factor-β Signaling-Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion
Nikki Cheng et al.
MOLECULAR CANCER RESEARCH (2008)
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-β receptor knockout fibroblasts promotes mammary tumorigenesis
Nikki Cheng et al.
CANCER RESEARCH (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
The logic of TGFβ signaling
Joan Massague et al.
FEBS LETTERS (2006)
Transforming growth factor β receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells
N Chattopadhyay et al.
MOLECULAR BRAIN RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
New insights into TGF-β-Smad signalling
P ten Dijke et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway
R Paumelle et al.
ONCOGENE (2002)
Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G1 is c-Myc dependent and independent of p27 suppression, cdk2 activation, or E2F1-dependent transcription
KA Walter et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells
A Kasza et al.
CYTOKINE (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
